https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520-%2520Jefferies%2520Conference%2520-%25208%253A7%253A2018.pdf
Investor Day
P O L Y O N E
I N V E S T O R
P R E S E N T A T I O N
A U G U S T 2 0 1 8
F O R W A R D L O O K I N G S T A T E M E N T S
PolyOne Corporation 2
•
•
•
•
•
•
•
•
•
U S E O F
N O N - G A A P
M E A S U R E S
PolyOne Corporation 3
•
•
•
V I S I O N
PolyOne Corporation 4
To be the world’s
premier provider of
specialized polymer
materials, services and
solutions
C O R E
V A L U E S
P E R S O N A L
V A L U E S
Honesty IntegrityRespect
Operational
Excellence
Commercial
Excellence
Specialization
Globalization
Collaboration ExcellenceInnovation
To be the world’s
premier provider of
specialized polymer
materials, services
and solutions
S A F E T Y F I R S T
PolyOne Corporation 5
1.3
1.1 1.1
0.85
0.65
0.57
0.54
0.97
0.84
0.74 0.74
0.69
0.57
2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
YTD
Injuries per 100 Workers
Spartech
Acquisition
PolyOne Corporation 6
P O L Y O N E
2 0 1 7 R E V E N U E | $ 3 . 2 B I L L I O N
Transportation
18%
Industrial
16%
Consumer
12%
Packaging
11%
Healthcare
11%
Wire & Cable
9%
Appliance
5%
United States
59%
Europe
14%
Asia
10%
Latin
America
9%
Canada
8%
PolyOne
Distribution
34%
Performance Products &
Solutions 21%
Specialty
Engineered
Materials
19%
Color
Additives &
Inks 26%
Segment End Market Geography
Building &
Construction
12%
Electrical &
Electronics
6%
2009 2010 2011 2012 2013 2014 2015 2016* 2017*
P R O O F O F P E R F O R M A N C E
C O N S E C U T I V E
Y E A R S
PolyOne Corporation 7
8
$0.13
$0.68
$0.82
$1.00
$1.31
$1.80
$1.96
$2.06
$2.21
2006 2017
“Where we were” “Where we are”
ROIC** 5.0% 14.0%
Operating Income
% of Sales
Color, Additives & Inks 1.7% 15.5%
Specialty Engineered
Materials
1.1% 12.1%
Performance Products
& Solutions
4.3% 10.7%
Distribution 2.6% 6.3%
A D J U S T E D E P S E X P A N S I O N
S U S T A I N A B L E P A T H T O D O U B L E - D I G I T E P S G R O W T H
PolyOne Corporation 8
P E O P L E P R O D U C T S P L A N E T P E R F O R M A N C E
Double digit
annual EPS
growth
strategic acquisitions
Innovate
600K-1M
commercial
resources 6-8%
Double acquired
margins
Lean Six Sigma
commercial excellence
531
689130
157
504
633
2014 Q2 2018
R&D / Technical Marketing Sales
PolyOne Corporation 9
Increased commercial headcount
+ 28%
+ 18%
+ 23%
Generating opportunities
35%
25%
1,000
$1.0B
Enhancing efficiency
8%
20%
I N V E S T M E N T I N C O M M E R C I A L R E S O U R C E S D R I V I N G G R O W T H
Lead
Specialists
T H E E V O L V I N G C U S T O M E R R E L A T I O N S H I P
PolyOne Corporation 10
Expanded Path
Traditional Path
Strategic Accounts/
Field Sales
Business
Development
Customer
Service
Web and Social
Media
Inside Sales
PolyOne Corporation 11
Investments in digital and dedicated inside sales to
improve customer experience
80% increase in leads (from 6,000 to 11,000) driven
by website, phone, and online chat
E X P A N D E D P A T H
A D D I N G C U S T O M E R T O U C H P O I N T S
4
21
2014 2017
Inside sellers
$11M
$88M
2014 2017
Inside sales/digital revenue
N E W R E S O U R C E S F U E L I N G T H E F U T U R E
PolyOne Corporation 12
P O L Y O N E
S A L E S
F U N N E L
+34%
2014
$3.0 billion
2017
$4.0 billion
A L I G N I N G W I T H T R E N D S F O R G R O W T H
T R A N S P O R T A T I O N P A C K A G I N G H E A L T H C A R E C O N S U M E R
PolyOne Corporation 13
Facilitate
alternative
energy
solutions
Light-
weighting
Reduce
packaging
materials
Improve
recyclability
Reduce
spread of
infection
I N N O V A T I O N
PolyOne Corporation 14
Customization
55%
M&A
30%
Innovation
Pipeline
15%
Innovation comes from Research & Development Spend
Vitality Index
12%
38%
2006 2017
$20
$52
2006 2017
Transformational
Adjacent
Core
3 H O R I Z O N S O F D E V E L O P M E N T
PolyOne Corporation 15
Market
Technical
I N N O V A T I O N
I N N O V A T I O N P I P E L I N E
PolyOne Corporation 16
PrototypeFrame
Opportunity
Scale-up & Test
Market
Build
Business Case
Commercial
Launch
(since 2015)
Phase 1 Phase 2 Phase 3 Phase 4 Phase 5
8
5
6
2 1
15 4
10
5
11
4
5
7
Breakthrough
Platform
Derivative
F L A M E
R E T A R D A N T
P O L Y M E R S
A D V A N C E D
C O M P O S I T E S
B A R R I E R
M A T E R I A L S
C O L O R A N T
T E C H N O L O G I E S
T H E R M O P L A S T I C
E L A S T O M E R S
I N N O V A T I O N S P O T L I G H T :
C O M P O S I T E S
PolyOne Corporation 17
C O M P O S I T E S R E F R E S H E R
PolyOne Corporation 18
Fiber
Polymer
Composite
S T R A T E G I C I N V E S T M E N T H I S T O R Y
Thermoplastic Composites
Long Fiber Reinforced Thermoplastics
Continuous Fiber Thermosets
Long Fiber Reinforced Thermoplastics
Continuous Fiber Thermosets
2012 2015 20162009 2011 2018
PolyOne Corporation 19
C O M P O S I T E S I N T R A N S P O R T A T I O N
PolyOne Corporation 20
W A T E R C R A F TR A I L H E A V Y T R U C K
PolyOne Corporation 21
Safety Technology Geography Service FinancialPeople
8-10% with
ability to double
I N V E S T - T O - G R O W M & A S T R A T E G Y
PolyOne Corporation 22
Capture
sourcing
synergies
Cross-sell
& blend
technology
8-10%
operating
margins
I N V E S T - T O - G R O W M & A P L A Y B O O K
Protect
customers
Retain
employees
Implement LSS to
drive efficiency
improvements
Innovate with
combined
portfolio
Safety
First!
�) ��$) ��*
$�� �&�� &.� �(
$* ��/ ��� �8�@
ABBCD
ABEBD
ABEED
ABEAD
ABEFD
ABEGD
ABEHD
ABEI
ABEJ
K LMN OPQRLS TQ
RPQOMN OUN OVQWL
TXMN QOYXMM TNZ UM
XZ[ L
M Q\ Q[ ]^ OLPQ
RRQOY_ XTL_ Q[̀ L
TY
a bcd ef
a bgh eg
a bgi ej
a gi ei
a kj ec
a fl ec
a bjj ed
a bdd ej
a bfi eg
m QN OM nLOM UTLLo
UNM ]LXTON OVY pX
SM LTM Xq
rbk ecs
rbj efs
ri efs
t
t
t
t
t
t
u WLPN X[NM LRY pZ L
S QTLM Xqv wx
rjl efs
hj ehr
jl ebs
gg eb
jd eib
dj eh
lf ed
hi el
ih ek
u WLPN X[NM LRY pM
XqXỳ UYM RLOM Yv w
x
rhf ehs
rkd efs
rhj efs
rbl eks
rbi efs
rfi efs
rgl efs
rbg eks
rhj els
z̀y UYM L` OLMN OP
QRLS TQRPQOMN O
UN OVQWLTXMN QOY
XMM TNZ UM XZ[ LM Q\
Q[ ]^ OLPQRRQO
Y_ XTL_ Q[̀ LTY
a bb el
a dg ei
a fd ek
a lk eg
a bhd ed
a bdl eg
a bfi eg
a bfj ei
a blb ed
{N[ UM L` Y_ XTLY
ki ej
kd ec
kj ei
lk el
kd eg
ki eg
ll ef
lj ed
lh eb
z̀y UYM L|̀\u XM
M TNZ UM XZ[ LM Q\ Q
[ ]^ OLPQRRQO
Y_ XTL_ Q[̀ LTY
a c ebi
a c edl
a c elh
a b ecc
a b eib
a b elc
a b ekd
a h ecd
a h ehb
}~� �� ��� ��� ������ ���
��� ������������ ��
� ���� ������ �������
������� ������ �� ��
� ����� ��� ��� ������� �
� ������ ��������� ��
��� ��� �� � ��� ������ ���
� ������� ������� ����
�� �� ��������� ��� �� �
���� ���� ���� ���� ���
�� ��� �������� �� ��� �
������� ��� ��� ��� �� ��
�� ��� ������� ����� �� �
��� ���� ��� ������ ����
������� ��� ���� ����
��� ����� ��� ���� ���� �
� ���� ���� ������ �� ��
������� ����� �� ���� ��� �
�� ������ ���� �������
������ ��������� �����
������� ������ ��������
��� ���
��������� ��� ���� ���
������� ��� ��� ����� �
����� ���� � �������� �
��������� ���������
�� �������� ���� ����� �
����� �� � ����� �� ��
��� ���� ������� �� ��
���� ��� ���� �� ��� ����
�� ������������ ���
�� ��� ������ ����� ���
���� ������ �� �������
� ������� �� ������ ��� �
�
���� � ��� ��� �������� ��
��� ��� �� ��� ��������
�������� ����� �� ��� �
� ������� ����� ������
���� ���� ����� ���� �
���������� ������ ���
������ ��� ������ ����
� ������� ��� ��� ������
� �� �� ���� �������
����� �� ����� ���� ���
�� ������ �������� ��
���� ���������� ���� ��
��
�� ������ �������� �����
�� ���� �� ��� ��������
���� �� ��� �����������
���� ��� ������ ����� ��
� ��� ��� ��� �������
����� ��� �������� ��� �
�� ������������� �
��� ����� ����������
� �� ���� ��� �� ���� ����
���� ���� ��������� �
��� ��� �� �� ������ ���
������ ����� ��� �� ���
�
��� ������� ������
���� �� ������ ���� ����
���� �� ������ � �¡ ����
��� ���� �� ��� �� ��� �
���� ��� ��������� ��
����� ������ ��� ��� ��
���� ���� ��� ��� ��
�� ������������� �� �
����� �� �� �������� ���
����������� �� �����
� ������ ����� ���� ��
��� �������� ��� ���� �
�
8.1.18 Investor Presentation V1.pdf
Non-GAAP Reconciliation - July 2018 (004).pdf
https://www.avient.com/products/engineered-polymer-formulations/chemical-corrosion-resistant-formulations/trilliant-hc-healthcare-thermoplastics
Safety Data Sheets
Technical Data Sheets
Browse our library of product data sheets containing technical descriptions and details.
https://www.avient.com/sites/default/files/2020-11/oncap-denesting-case-study.pdf
To solve this issue, the converter
required immediate action from the sheet producer.
The sheet producer began experimenting with material
changes in-house, but struggled to achieve consistency
of release.
THE IMPACT
While the OnCap Denesting additive solution was
developed initially to satisfy the needs of the converter,
it was so effective that the sheet producer has plans to
incorporate this technology into its entire portfolio of
packaging solutions.
https://www.avient.com/sites/default/files/resources/POL%2520Sidoti%2520IR%2520Presentation%2520w%2520Non%2520GAAP%25203%252018%25202014.pdf
Strong past performance demonstrates that our strategy and
execution are working
• Megatrends align with our strengths
• Innovation and services provide differentiation, incremental
pricing power, and competitive advantage
• Strong and proven management team driving growth and
performance
• Addressable market exceeds $40 billion
Page 14
1
Schedule I
Reconciliation of Non-GAAP Financial Measures (Unaudited)
(Dollars in millions, except per share data)
Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and presented
in accordance with U.S.
Reconciliation to Condensed Consolidated Balance Sheets 2013
Short-term debt and current portion of long-term debt $ 12.7
Long-term debt 976.2
Less cash and cash equivalents (365.2)
Net debt $ 623.7
Adjusted EBITDA 2013
Income before income taxes $ 151.0
Interest expense, net 63.5
Depreciation and amortization 108.8
Special items in EBITDA 31.7
Adjusted EBITDA $ 355.0
2
Platform sales and operating income (OI) 2006Y* 2013Y
Global Specialty Engineered Materials sales $ 345.3 $ 615.5
Global Color, Additives and Inks sales 531.8 852.3
Designed Structures and Solutions sales - 597.4
Specialty Platform sales 877.1 2,065.2
Performance Products and Solutions sales 1,166.2 773.2
PolyOne Distribution sales 732.8 1,075.2
Corporate and eliminations (153.7) (142.4)
Total sales $ 2,622.4 $ 3,771.2
Global Specialty Engineered Materials OI $ 3.9 $ 57.2
Global Color, Additives and Inks OI 8.9 104.0
Designed Structures & Solutions OI - 33.4
Specialty Platform OI 12.8 194.6
Performance Products and Solutions OI 64.2 56.0
PolyOne Distribution OI 19.2 63.3
Sunbelt Joint Venture OI 102.9 -
Corporate and eliminations (4.6) (52.4)
Special items in OI 39.1 (30.0)
Operating income GAAP 233.6 231.5
Sunbelt equity income (107.0) -
Special items in OI (39.1) 30.0
Adjusted operating income $ 87.5 $ 261.5
Global Specialty Engineered Materials - OI % of sales 1.1% 9.3%
Global Color, Additives and Inks - OI % of sales 1.7% 12.2%
Designed Structures & Solutions - OI % of sales - 5.6%
Specialty platform OI - % of sales 1.5% 9.4%
PP&S operating OI - % of sales 5.5% 7.2%
Distribution OI - % of sales 2.6% 5.9%
PolyOne OI adjusted - % of sales 3.3% 6.9%
* Historical results include the Resin and Specialty Coatings businesses within the Performance Products and Solutions segment.
PolyOne Investor Presentation��Sidoti & Company �Eighteenth Annual Emerging Growth �Institutional Investor Forum�March 18, 2014�
Forward – Looking Statements
Use of Non-GAAP Measures
PolyOne Commodity to Specialty Transformation
Strategy and Execution Drive Results
PolyOne�At A Glance
Mix Shift Highlights Specialty Transformation
Proof of Performance & 2015 Goals
Bridge To $2.50 Adjusted EPS By 2015
Innovation Drives Earnings Growth
Unique and Innovative Solutions that Help Customers Win
Debt Maturities & Pension Funding – 12/31/13
Free Cash Flow and Strong Balance Sheet Fund Investment
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/2022-07/REMAFIN EP White Masterbatches for Pharma Application Bulletin_CN.pdf
主要特性
生产符合高于CAS编号级别的变更控制原则
(与MEVOPUR母粒类似),降低变更风险
不含动物源性物质和邻苯二甲酸盐
适用于吹膜、注塑、吹塑和挤出
•
•
•
注册药品主文件(III型)
食品接触符合FDA/EU*要求
法规支持
原材料根据以下法规测试:
- ISO 10993-1
- USP第、章,包括VI级别,符合眼
科和鼻腔用药物要求
- 欧洲药典3.1.3/3.1.5(聚烯烃)
- 美国药典(聚乙烯)
- ICH Q3D 杂质元素
- USP和USP,透光率
•
•
•
载体材料 耐光性 热稳定性 产品代码颜料含量/类型
HDPE 50% TiO2 8 300°C PH00075525
LLDPE 60% TiO2 8 300°C PL00075542
LLDPE 70% TiO2 8 300°C PL00075545
PP 50% TiO2 8 300°C PP00075717
适用医疗保健使用限制—见下文。
https://www.avient.com/sites/default/files/2024-03/2024 Proxy Statement_March.pdf
In July 2020, following our transformational acquisition of Clariant
Color, we branded the collective enterprise as Avient —a new name, for a new kind of materials company.
Safety and Health
The top priority at Avient is the safety and health of our associates, and our ultimate goal is to operate
injury free.
The second independent source of data that we used to augment the peer proxy analysis was the
Consultant’s analysis of competitive market data relating to other applicable general industries.
https://www.avient.com/sites/default/files/resources/POL%2520Gabelli%2520IR%2520Presentation%2520w%2520Non-GAAP%252003%252020%25202014.pdf
Strong past performance demonstrates that our strategy and
execution are working
• Megatrends align with our strengths
• Innovation and services provide differentiation, incremental
pricing power, and competitive advantage
• Strong and proven management team driving growth and
performance
• Addressable market exceeds $40 billion
Page 14
1
Schedule I
Reconciliation of Non-GAAP Financial Measures (Unaudited)
(Dollars in millions, except per share data)
Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and presented
in accordance with U.S.
Reconciliation to Condensed Consolidated Balance Sheets 2013
Short-term debt and current portion of long-term debt $ 12.7
Long-term debt 976.2
Less cash and cash equivalents (365.2)
Net debt $ 623.7
Adjusted EBITDA 2013
Income before income taxes $ 151.0
Interest expense, net 63.5
Depreciation and amortization 108.8
Special items in EBITDA 31.7
Adjusted EBITDA $ 355.0
2
Platform sales and operating income (OI) 2006Y* 2013Y
Global Specialty Engineered Materials sales $ 345.3 $ 615.5
Global Color, Additives and Inks sales 531.8 852.3
Designed Structures and Solutions sales - 597.4
Specialty Platform sales 877.1 2,065.2
Performance Products and Solutions sales 1,166.2 773.2
PolyOne Distribution sales 732.8 1,075.2
Corporate and eliminations (153.7) (142.4)
Total sales $ 2,622.4 $ 3,771.2
Global Specialty Engineered Materials OI $ 3.9 $ 57.2
Global Color, Additives and Inks OI 8.9 104.0
Designed Structures & Solutions OI - 33.4
Specialty Platform OI 12.8 194.6
Performance Products and Solutions OI 64.2 56.0
PolyOne Distribution OI 19.2 63.3
Sunbelt Joint Venture OI 102.9 -
Corporate and eliminations (4.6) (52.4)
Special items in OI 39.1 (30.0)
Operating income GAAP 233.6 231.5
Sunbelt equity income (107.0) -
Special items in OI (39.1) 30.0
Adjusted operating income $ 87.5 $ 261.5
Global Specialty Engineered Materials - OI % of sales 1.1% 9.3%
Global Color, Additives and Inks - OI % of sales 1.7% 12.2%
Designed Structures & Solutions - OI % of sales - 5.6%
Specialty platform OI - % of sales 1.5% 9.4%
PP&S operating OI - % of sales 5.5% 7.2%
Distribution OI - % of sales 2.6% 5.9%
PolyOne OI adjusted - % of sales 3.3% 6.9%
* Historical results include the Resin and Specialty Coatings businesses within the Performance Products and Solutions segment.
PolyOne Investor Presentation��Gabelli & Company �5th Annual Specialty Chemical Conference�March 20, 2014�
Forward – Looking Statements
Use of Non-GAAP Measures
PolyOne Commodity to Specialty Transformation
Strategy and Execution Drive Results
PolyOne�At A Glance
Mix Shift Highlights Specialty Transformation
Proof of Performance & 2015 Goals
Bridge To $2.50 Adjusted EPS By 2015
Innovation Drives Earnings Growth
Unique and Innovative Solutions that Help Customers Win
Debt Maturities & Pension Funding – 12/31/13
Free Cash Flow and Strong Balance Sheet Fund Investment
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/2024-01/AVNT January IR Presentation_w Non-Gaap Recs.pdf
GUIDANCE
$800
$754
Guidance Actual
$128
$123
Guidance Actual
Sales Adjusted EBITDA
(in millions)
$0.56 $0.57
Guidance Actual
Adjusted EPS
(in millions)
13
• Demand impacted by destocking
and cautious customer sentiment
• Positive net price benefit:
o CAI - Pricing flat and raw
material deflation
o SEM - Pricing flat with
unfavorable mix related to
healthcare, more than offset
with raw material deflation
• Cost reductions driven by Clariant
synergies and reduced
administrative costs
Q3 EBITDA BRIDGE
($ millions)
CAI:
Price / Mix -)
Deflation 22)
SEM:
Price / Mix (6)
Deflation 13)
Net Price Benefit 29)
Cost Reductions 13)
Wage Inflation (8)
FX 1)
Q3 2023 Actual $ 123)
Adjusted
EBITDA
Q3 2022 Pro Forma $ 137)
Demand (49)
14
2 0 2 3 G U I D A N C E
Q4 2023 GUIDANCE VS.
PRIOR YEAR
$790
$710
2022 2023
$107
$112
2022 2023
Sales Adjusted EBITDA
(in millions)
$0.42
$0.47
2022 PF 2023
Adjusted EPS
(in millions)
- 10% + 5% + 12%
Sales Adjusted EBITDA Adjusted EPS
16
$112
$500
Q4 FY
$0.47
$2.30
Q4 FY
Q4 AND FULL YEAR 2023 GUIDANCE
$710
$3,130
Q4 FY
Sales Adjusted EBITDA Adjusted EPS
17
(in millions) (in millions)
Guidance: Free Cash Flow
$180 $180
Prior Guidance Guidance
FREE CASH FLOW & INCREASED DIVIDEND
13th Consecutive Dividend Increase
0.16
0.26
0.42
0.58
0.79
0.85
0.99
1.03
2011 2013 2015 2017 2019 2021 2023 2024
18
S U S T A I N A B I L I T Y D AY
R E C A P
SUSTAINABILITY AS A GROWTH DRIVERLONG-TERM REVENUE GROWTH DRIVERS
60%+
Key Growth
Drivers
Sustainable
Solutions
Composites, Healthcare,
Asia / LATAM
Overlap
Other
(GDP Growth)
Total Company Revenue
Growth Drivers Long-Term Growth Rate
Sustainable Solutions 8–12%
Composites 8–10%
Healthcare 8–10%
Asia / LATAM 5%
Other (GDP growth) 0–2%
Avient 6%
20
SUSTAINABILITY TRENDS DRIVE LONG-TERM GROWTH
8-12%
Long Term
Growth
50
90
2022 2030
Medical Plastics
Market Size
(in $Billions)
2020 2030
Recycled
Plastics
Virgin
Plastics
Growing Demand
for Recycled
Content
Avient Sustainable
Solutions
18
46
2023 2032
Global Offshore Annual
Wind Installations
(in Gigawatts)
Sources: McKinsey, Bloomberg, Grand View Research
SUSTAINABILITY TRENDS DRIVE
LONG-TERM GROWTH
21
• Transformative acquisitions
combined with divestitures of
more cyclical businesses have
improved margins over 400 bps
since 2018
• 20% long-term margin goal to
be driven by key growth drivers,
with sustainable solutions
playing a meaningful role
5.4%
11.5%
16.0%
2006 2018 2023E Recovery Growth
Drivers
Strategic
Objective
20%+
+1%+
+3%+
ADJUSTED EBITDA MARGIN EXPANSION
22
• 6% annualized long-term sales growth leveraging
sustainable solutions, composites, healthcare, and
emerging regions
• Expand EBITDA margins to 20%
• Deliver annual EBITDA and EPS growth of
10% and 15%
• Maintain asset-light, 80% free cash flow conversion
profile and be valued as a specialty formulator
• Continue fostering our Great Place to Work® culture
CRE AT ING A WORL D-CL AS S
S US TAINABL E ORGANIZ AT ION
23
PEER COMPARISONS
AVIENT IS ASSET LIGHT
Capex / Revenue
2023E (%)
Avient Specialty
Formulators
Other Specialty /
Chemical Companies
Source: Peer data per Bloomberg as of December 29, 2023
Note: Avient reflects 2023 estimated revenue of $3,130 and estimated run-rate CAPEX of $110M.
26
3.5
1.8
2.7
3.1 3.3
3.7
3.0
3.7
4.7 4.8
6.8 6.8
8.7
11.1
A
vi
en
t
K
W
R
FU
L
P
P
G
A
V
Y
R
P
M
FM
C
H
U
N
C
E
E
C
L
H
X
L
A
S
H
E
M
N
S
C
L
FREE CASH FLOW CONVERSION
Source: Peer data per Bloomberg as of December 29, 2023
Note: Free cash flow conversion calculated as (Adjusted EBITDA – Capex) / Adjusted EBITDA.
Avient reflects 2023 adjusted EBITDA guidance of $500M and estimated run-rate CAPEX of $110M.
2023E (%)
27
78
89
83 80 78
74
86
79 76
67 66
55
50
(39)
A
vi
en
t
K
W
R
FU
L
P
P
G
A
V
Y
R
P
M
FM
C
C
E
E
C
L
A
S
H
H
X
L
H
U
N
E
M
N
S
C
L
Avient Specialty
Formulators
Other Specialty /
Chemical Companies
MULTIPLE EXPANSION
Source: Peer data per Bloomberg as of December 29, 2023
Note: Avient reflects 2023 adjusted EBITDA guidance of $500M and closing share price of $41.57.
https://www.avient.com/knowledge-base/article/designing-parts-meet-sustainability-goals
Download PDF
https://www.avient.com/sites/default/files/2021-01/certificate-of-amendment-modification-avient-colorants-canada-inc.pdf
Form 4
Canada Business Corporations Act
(CBCA) (s. 27 or 177)
Formulaire 4
Loi canadienne sur les sociétés par
actions (LCSA) (art. 27 ou 177)
Articles of Amendment Clauses modificatrices
Corporate name
Dénomination sociale
1
Clariant Plastics & Coatings Canada Inc.